Letairis Treats Pulmonary Arterial Hypertension
Dayton Daily News - MONDAY, June 18 (HealthDay News) — The U.S. Food and Drug Administration has approved the drug Letairis (ambrisentan) to treat pulmonary arterial hypertension, a rare but life-threatening condition marked by continuous high blood pressure within the …
